Nautilus Biotechnology Investor Relations Material
Latest events
Q3 2024
Nautilus Biotechnology
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Nautilus Biotechnology Inc
Access all reports
Nautilus Biotechnology, Inc. is a life sciences company specializing in the development of a next-generation platform for proteomics research. The company's technology is designed to identify and quantify proteins with high sensitivity, aiming to advance scientific discovery and improve healthcare outcomes. Nautilus focuses on enabling researchers to study the proteome at unprecedented depth and scale, which could support advancements in drug discovery, diagnostics, and personalized medicine. The company is headquartered in Seattle, Washington, and its shares are listed on the NASDAQ.
Key slides for Nautilus Biotechnology Inc
Q3 2024
Nautilus Biotechnology Inc
Q3 2024
Nautilus Biotechnology Inc
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
NAUT
Country
🇺🇸 United States